Rifampicin for continuation phase tuberculosis treatment in Uganda: a cost-effectiveness analysis

Translated title of the contribution: Rifampicin for continuation phase tuberculosis treatment in Uganda: a cost-effectiveness analysis

Y.C. Manabe, S.M. Hermans, M. Lamorde, B. Castelnuovo, C.D. Mullins, A. Kuznik

Research output: Contribution to journal › Article › Academic › peer-review

Translated title of the contribution	Rifampicin for continuation phase tuberculosis treatment in Uganda: a cost-effectiveness analysis
Original language	Undefined/Unknown
Pages (from-to)	e39187
Number of pages	1
Journal	PLoS ONE [E]
Volume	7
Issue number	6
Publication status	Published - 2012

Cite this

@article{e5cf1978ffc74a4b8831e16a1e119d07,

title = "Rifampicin for continuation phase tuberculosis treatment in Uganda: a cost-effectiveness analysis",

author = "Y.C. Manabe and S.M. Hermans and M. Lamorde and B. Castelnuovo and C.D. Mullins and A. Kuznik",

year = "2012",

language = "Undefined/Unknown",

volume = "7",

pages = "e39187",

journal = "PLoS ONE [E]",

issn = "1932-6203",

publisher = "Public Library of Science",

number = "6",

}